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Meningitis and brain abscess caused by carbapenemase-producing Klebsiella pneumoniae (KPC) is rarely
described in the medical literature. Such infections have been described after neurosurgical medium or
post-trauma. We describe an unusual case of KPC meningitis originating from with long term intravenous
antibiotics.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
Carbapenemase producing enterobacteriaceae such as Klebsiella pneumoniae are well recognized infections across the globe.
These infections have gained importance because it is not only
resistant to many antimicrobials; they pose a serious challenge for
clinicians for effective treatment options. We report an unusual
case of chronic otitis media leading to meningitis in a patient
presenting from home.
Abstract
Meningitis and brain abscess caused by carbapenemaseproducing Klebsiella pneumoniae (KPC) is rarely described in the
medical literature. Such infections have been described after
neurosurgical medium or post-trauma. We describe an unusual
case of KPC meningitis originating from chronic otitis media and
subsequent resolution with long term intravenous antimicrobials.
Case report
A 68-year old female with a past medical history of stable
chronic obstructive pulmonary disease, hypertension, non-small
cell lung carcinoma in remission, aortic aneurysmal repair, and
splenectomy presented from home with acute left-sided worsening otalgia. The patient gradually developed symptoms three
months prior to the presentation which worsened over the past
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week and was prescribed amoxicillin-clavulanate and eardrops
with no improvement of the symptoms. The pain was constant
sharp, severe, involving the left side of her face with no relieving
factors and affecting the left side hearing. No other motor or
sensory deﬁcits and nuchal rigidity were reported. On physical
examination, the patient was found to have pre and post auricular
tenderness with no temporal tenderness. The ear canal was clear
with no visible drainage, tympanic membrane was mildly
erythematous.
Vital signs were within normal limits (temperature 36.7 C,
respiratory rate 12 with SpO2 99 % on room air, heart rate 88 bpm,
and blood pressure 165/80 mmHg) with no evidence of SIRS on
admission. The initial blood workup had a white cell count of
8,000 /mL with normal neutrophil, lymphocyte count, hemoglobin
on 10.8 g/dL, and platelet 350,000/mL along with a normal
comprehensive metabolic panel.
Emergent computed tomographic study of the head was
obtained which demonstrated clouding of the left mastoid air
cells associated with ﬂuid in the left middle ear suggestive of
acute left mastoiditis and otitis media. Blood cultures were
obtained, and the patient was prophylactically started on
vancomycin and cefepime with oﬂoxacin ear drops. Given the
unusual presentation of unilateral facial pain, trigeminal
neuralgia was considered as a differential diagnosis and she
was initially kept on carbamazepine. A CT scan with intravenous
contrast of the orbits re-demonstrated left-sided mastoiditis and
otitis media without osseous erosion however, the left petrous
apex showed inﬂammation suggestive of meningitis (with no
clinical evidence of meningeal signs) and cranial fossa osteomyelitis (Fig. 1). The patient underwent lumbar puncture and CSF
analysis (Table 1) with cultures were obtained.
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Fig. 1. CT orbits with contrast.
Table 1
CSF Analysis.

Table 2
Blood culture sensitivities.

CSF color

Slight Pinkish

ANTIBIOTICS

SENSITIVITIES

Appearance
Total CSF Nucleated Cell count
CSF RBC
CSF Neutrophils
CSF Lymphocytes
CSF Macrophages/Monocytes
CSF Lactate dehydrogenase

Clear
22
397
40 %
52 %
8%
29

Amikacin
Ampicillin
Ampicillin/Sulbactam
Aztreonam
Cefazolin
Cefepime
Cefoxitin
Ceftazidime/Avibactam
Ceftolozane/Tazobactam
Ceftriaxone
Ciproﬂoxacin
Gentamicin
Imipenem
Levoﬂoxacin
Meropenem
Piperacillin/Tazobactam
Tigecycline
Tobramycin
Polymyxin B
Colistin

S< = 16
R>16
R>16
R>16
R>16
R>16
S< = 8
S< = 4
R8
R>32
R2
S< = 2
I2
I1
S< = 1
R 64
S<=2
S< = 2
S< = 0.25
S1

When the preliminary blood and lumbar tap cultures grew
gram-negative rods, the cefepime was switched to meropenem.
The patient was also initiated on prophylactic valproic acid antiepileptic and a 20-minute electroencephalogram was obtained to
rule out seizures secondary to infectious etiology. A magnetic
resonance imaging (MRI) of the head with and without gadolinium
was obtained (Fig. 2) which demonstrated left-sided otomastoiditis and petrous apicitis with 1 cm abscess formation in the left
petrous apex. Dural enhancement was also noted on the left

Table 3
CSF culture sensitivities.

Fig. 2. MRI with and without contrast showing abscess.

ANTIBIOTICS

SENSITIVITIES

Amikacin
Ampicillin
Ampicillin/Sulbactam
Aztreonam
Cefepime
Ceftazidime/Avibactam
Ceftolozane/Tazobactam
Ceftriaxone
Gentamicin
Meropenem
Tobramycin

S< = 16
R>16
R>16
R>16
R>16
S< = 4
R8
R>32
S< = 2
S< = 1
S< = 2

middle cranial fossa and left cerebellopontine angle cistern
extending into the internal auditory canal, left prepontine cistern,
and left tentorium consistent with meningitis.
When initial blood and CSF cultures resulted in carbapenemase-producing Klebsiella pneumoniae (KPC), the antibiotic
coverage was switched to polymyxin and ceftazidime/avibactam
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Fig. 3. Repeat MRI showing resolution of the abscess.

with improvement in the symptoms. When the ﬁnal cultures
resulted (Tables 2 and 3) the patient was transitioned to polymyxin
and meropenem/vaborbactam. The blood cultures and lumbar
puncture was repeated to document clearance of bacteremia and
infection in the CSF ﬂuid. All the repeat cultures were resulted in
negative. An external ear canal culture was also collected to check
for colonization was negative. The patient was discharged home to
complete the antibiotic course of polymyxin for two weeks and
ceftazidime/avibactam for six weeks from the ﬁrst day of negative
blood and CSF culture along with outpatient follow up at the
infectious disease clinic.
The patient was followed up after ﬁnishing the antibiotic
course. She demonstrated no new complaints with the resolution
of her symptoms. A repeat MRI of the head was obtained which
showed interval improvement of the leptomeningeal enhancement (Fig. 3).
Description
Antimicrobial resistance to carbapenem through carbapenem
hydrolyzing beta-lactamase (carbapenemase) in a gram-negative
organism is well-known in current infectious disease literature.
This antimicrobial resistance on the molecular level has been
classiﬁed based on various sub-groups- Class A, D, and B including
NDM-1. In the United States, carbapenemase-producing Klebsiella
(KPC) infections are most reported which belongs to Class A. The
epicenter for Class B, NDM-1 is described in Europe and Indian
subcontinents whereas Class D is noted in Europe and the Middle
East [1].
Class A organisms are characterized by their unique betalactam hydrolytic enzymes conferring them with resistance to
penicillin, cephalosporins, and carbapenems. These features may
either be chromosomally encoded or transmitted via plasmids.
KPC has acquired the resistance through the transmissible
plasmids and a spectrum of KPC enzymes have been identiﬁed
providing a variety of susceptibility proﬁles to antibiotics in
these carbapenem-resistant organisms [2]. KPC has been
described as a causative agent for serious nosocomial infections
like pneumonia, urinary tract infections, intra-abdominal
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infections, and septicemia. Some evidence is also available
suggesting intestinal and nasopharyngeal mucous membrane
colonization and subsequent emergence as an opportunistic
infection in critically ill patients, however, the risk factors are not
properly understood. Community-acquired infections due to KPC
are less commonly reported [3,4]. An ear canal culture of our
patient was obtained to check for colonization with KPC, which
was negative.
Several common characteristics have been described of
individuals with KPC infection which include age >70 years,
comorbidities like COPD, diabetes, renal insufﬁciency, malignancy, immunocompromised states, and residence at skilled nursing
and long-term facilities. Though it is interesting to note
approximately 28 % population presenting with KPC can come
from a community with no recent exposure to healthcare-related
facilities [5]. Our patient who presented from home had several
of these characteristic risk factors COPD, history of non-small
cell carcinoma in remission, and immunocompromised state due
to splenectomy. KPC meningitis majorly results as a post
neurosurgical/traumatic complication. The most unique fact
about our clinical scenario was that meningitis and abscess
formation occurred as an ascending infection from possible
chronic otitis media, such presentation and occurrence of
community-acquired meningitis has not been described in
medical literature to the best of our knowledge [6,7].
The optimal treatment of carbapenemase-producing organisms like KPC is dependent upon the available antibiotic
susceptibility data. The use of novel beta lactam-beta
lactamase inhibitor combination like ceftazidime/avibactam
agents has shown promising results due to better safety proﬁle,
reliable dosing, and appropriate susceptibility rates [8].
Serious infections with carbapenemase-producing organisms
such as meningitis are often associated with a very high
mortality rate and the rationale to use combination therapy
has shown to improve the survival beneﬁt [9]. Our patient
showed signiﬁcant improvement in combination therapy with
polymyxin and ceftazidime/avibactam, supporting its use for
KPC infections.
Conclusion
In this case report, we discuss an unusual case of KPC
bacteremia and meningitis without evident clinical symptoms
and signs and originating likely from chronic otitis media. The
patient was successfully managed with long term intravenous
antibiotics in combination therapy. The medical literature suggests
that complicated KPC infections pose a serious threat with a high
mortality rate. Our case report stands among the few clinical cases
with good clinical outcomes.
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